Drug intelligence / Profile preview

LIVOKAS

Development stage: Unknown
Lead developer: Kaiser Drugs
Modality: Small Molecules
Administration: Oral

Overview

LIVOKAS (Liver Care Drops) is an Ayurvedic polyherbal formulation developed and marketed by Kaiser Drugs Private Limited. It is designed to support liver health and is indicated for conditions such as jaundice, hepatomegaly (enlargement of the liver), anorexia, chronic hepatitis, constipation, and alcoholic liver disease. The formulation contains a blend of traditional medicinal herbs including Bhuiamalki (*Phyllanthus niruri*), Kalmegh (*Andrographis paniculata*), and Kasani (*Cichorium intybus*), which are traditionally recognized for their hepatoprotective, anti-inflammatory, and antioxidant properties. It is administered orally as drops and is marketed as a safe, herbal supplement with minimal side effects.

Brand names: LIVOKASLiver Care Drops
Other names: LIVOKAS Drops

Beyond the preview

Go deeper on LIVOKAS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIVOKAS.

Explore the full profile